Establishing a Clinical Adoption Pathway for Point-of-Care
Point of Care Manufacturer (UAE)
Situation
A point-of-care diagnostics manufacturer sought to establish its presence in the UAE through an appointed distribution partner. Early feedback from the distributor indicated that market access would be difficult due to procurement pathways and limited perceived demand, creating uncertainty around the viability of the market.
Approach
Biocentric was engaged to provide independent regional perspective and assess the true commercial and clinical landscape. This included direct engagement with relevant healthcare stakeholders to understand procurement pathways, clinical workflows, and potential adoption pathways.
Through structured regional engagement, Biocentric worked to clarify the appropriate positioning of the product within the clinical pathway and facilitated discussions with leading public and private healthcare institutions to assess clinical interest and adoption potential.
Outcome
The engagement provided clear evidence of clinical interest and enabled the manufacturer to initiate pilot evaluations within leading healthcare institutions. This created a defined pathway toward clinical adoption and provided the manufacturer with a clearer foundation for long-term commercial establishment.
Biocentric’s involvement provided independent validation of market potential, ensuring that regional expansion decisions were informed by direct market engagement rather than relying solely on initial distributor feedback.